pre-IPO PHARMA

oncoceutics PRESS RELEASE ARCHIVE

Nov 17, 2021

Regen BioPharma, Inc. Announces Signing of a Letter of Intent to Acquire an In vitro Diagnostics Start-Up Company Canary Oncoceutics, Inc. Which is Developing Functional Cancer Tests for Personalized Medicine


Jan 21, 2016

Oncoceutics Begins Fifth Clinical Trial for ONC201


Oct 6, 2015

Oncoceutics Closes Series A Financing for First-in-Class Cancer Drug


Sep 29, 2014

Spring Mountain Capital Leads Investment in Oncoceutics


Google Analytics Alternative